Personalized Prediction of Future Lesion Activity and Treatment Effect in Multiple Sclerosis from Baseline MRIDownload PDF

10 Dec 2021, 01:53 (edited 22 Jun 2022)MIDL 2022Readers: Everyone
  • Keywords: counterfactual, treatment effect, causal inference, neuroimaging, precision medicine, multiple sclerosis, new and enlarging lesions, CATE, MRI, predicting future outcomes
  • TL;DR: We develop a medical imaging-based deep learning model for precision medicine which can be used to find sub-groups with heterogeneous treatment effects.
  • Abstract: Precision medicine for chronic diseases such as multiple sclerosis (MS) involves choosing a treatment which best balances efficacy and side effects/preferences for individual patients. Making this choice as early as possible is important, as delays in finding an effective therapy can lead to irreversible disability accrual. To this end, we present the first deep neural network model for individualized treatment decisions from baseline magnetic resonance imaging (MRI) (with clinical information if available) for MS patients which (a) predicts future new and enlarging T2 weighted (NE-T2) lesion counts on follow-up MRI on multiple treatments and (b) estimates the conditional average treatment effect (CATE), as defined by the predicted future suppression of NE-T2 lesions, between different treatment options relative to placebo. Our model is validated on a proprietary federated dataset of 1817 multi-sequence MRIs acquired from MS patients during four multi-centre randomized clinical trials. Our framework achieves high average precision in the binarized regression of future NE-T2 lesions on five different treatments, identifies heterogeneous treatment effects, and provides a personalized treatment recommendation that accounts for treatment-associated risk (side effects, patient preference, administration difficulties).
  • Registration: I acknowledge that publication of this at MIDL and in the proceedings requires at least one of the authors to register and present the work during the conference.
  • Authorship: I confirm that I am the author of this work and that it has not been submitted to another publication before.
  • Paper Type: validation/application paper
  • Primary Subject Area: Application: Radiology
  • Secondary Subject Area: Integration of Imaging and Clinical Data
  • Confidentiality And Author Instructions: I read the call for papers and author instructions. I acknowledge that exceeding the page limit and/or altering the latex template can result in desk rejection.
5 Replies

Loading